跳至主要内容
临床试验/NCT05442177
NCT05442177已完成不适用

Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

Taichung Tzu Chi Hospital0 个研究点目标入组 35 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
主要终点
Chemotherapy-induced Hematologic Toxicity

研究概览

简要总结

We conducted an observational study to investigate the effectiveness and safety of Integrated Chinese Medicine With Western Medicine for bone marrow suppression induced by chemotherapy in patients with cancer. The TCM constitution and pulse diagnosis was also observed in the study.

详细描述

Patients with cancer under chemotherapy and integrated Western and Chinese medicine were enrolled in this observational study. The assessment of radial pressure pulse (RPP) was performed before and after chemotherapy. The correlation between the spectral energy (SE0-10 Hz, SE10-50 Hz, and SE13-50 Hz) of the RPP at six diagnosis positions and the blood cell counts before and after chemotherapy were analyzed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with cancer diagnosed through pathological histology
  • Patients with cancer under chemotherapy and Integrated Chinese Medicine With Western Medicine
  • Patients with an Eastern Cooperative Oncology Group Performance score of 0-2
  • Patients having normal liver and kidney functions and electrocardiography and eligible for chemotherapy with normal bone marrow hematopoietic function
  • Patients who were voluntarily involved in this study

排除标准

  • Cases that did not meet the inclusion criteria
  • Patients who could not cooperate with pulse diagnosis
  • Patients with underlying diseases such as chronic obstructive pulmonary disease, cardiac failure, chronic renal failure, cirrhosis, etc.
  • Patients with severe infection
  • Patients with severe cachexia

结局指标

主要结局

Chemotherapy-induced Hematologic Toxicity

时间窗: one month

the blood cell count before and after chemotherapy was collected for measurement of severity of myelosuppression

次要结局

未报告次要终点

研究者

发起方
Taichung Tzu Chi Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chia-Ying Chuang

Chinese medicine department

Taichung Tzu Chi Hospital

相似试验